Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn
About

Company News Summary

CSL Provides FY 2021 Results Presentation

18 Aug 2021  |  08:42:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: CSL Results Presentation

CSL provided FY 2021 results presentation. It reported Record volume of 130m doses distributed globally. The Albumin Sales are up 61%; Immunoglobulins Sales are up 3%; CSL Behring Revenue is up 6%, Specialty Products Sales are up 2%; and Seqirus Revenue is up 30%. It noted NPAT of $2,375m.

Please click here for full details

See more ASX300 News Announcements